| VDJdb: a curated database of T-cell receptor sequences with known antigen specificity M Shugay, DV Bagaev, IV Zvyagin, RM Vroomans, JC Crawford, G Dolton, ... Nucleic acids research 46 (D1), D419-D427, 2018 | 443 | 2018 |
| VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium DV Bagaev, RMA Vroomans, J Samir, U Stervbo, C Rius, G Dolton, ... Nucleic acids research 48 (D1), D1057-D1062, 2020 | 334 | 2020 |
| Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 MD Crowther, G Dolton, M Legut, ME Caillaud, A Lloyd, M Attaf, ... Nature immunology 21 (2), 178-185, 2020 | 242 | 2020 |
| Peptide–MHC class I tetramers can fail to detect relevant functional T cell clonotypes and underestimate antigen-reactive T cell populations C Rius, M Attaf, K Tungatt, V Bianchi, M Legut, A Bovay, M Donia, ... The Journal of Immunology 200 (7), 2263-2279, 2018 | 92 | 2018 |
| VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2 M Goncharov, D Bagaev, D Shcherbinin, I Zvyagin, D Bolotin, PG Thomas, ... Nature methods 19 (9), 1017-1019, 2022 | 78 | 2022 |
| Optimized peptide–MHC multimer protocols for detection and isolation of autoimmune T-cells G Dolton, E Zervoudi, C Rius, A Wall, HL Thomas, A Fuller, L Yeo, ... Frontiers in immunology 9, 1378, 2018 | 78 | 2018 |
| Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope G Dolton, C Rius, MS Hasan, A Wall, B Szomolay, E Behiry, T Whalley, ... Cell 185 (16), 2936-2951. e19, 2022 | 67 | 2022 |
| T-cell libraries allow simple parallel generation of multiple peptide-specific human T-cell clones SM Theaker, C Rius, A Greenshields-Watson, A Lloyd, A Trimby, A Fuller, ... Journal of immunological methods 430, 43-50, 2016 | 43 | 2016 |
| Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy G Dolton, C Rius, A Wall, B Szomolay, V Bianchi, SAE Galloway, ... Cell 186 (16), 3333-3349. e27, 2023 | 38 | 2023 |
| Peptide super-agonist enhances T-cell responses to melanoma SAE Galloway, G Dolton, M Attaf, A Wall, A Fuller, C Rius, V Bianchi, ... Frontiers in immunology 10, 319, 2019 | 20 | 2019 |
| CD4+ T cells recognize conserved influenza a epitopes through shared patterns of V-gene usage and complementary biochemical features A Greenshields-Watson, M Attaf, BJ MacLachlan, T Whalley, C Rius, ... Cell reports 32 (2), 2020 | 15 | 2020 |
| Cytoplasmic accumulation of NCoR in malignant melanoma: Consequences of altered gene repression and prognostic significance F Gallardo, A Padrón, R Garcia-Carbonell, C Rius, A González-Perez, ... Oncotarget 6 (11), 9284, 2015 | 9 | 2015 |
| Cytomegalovirus-mediated T cell receptor repertoire perturbation is present in early life M Attaf, J Roider, A Malik, C Rius Rafael, G Dolton, AJ Prendergast, ... Frontiers in immunology 11, 1587, 2020 | 7 | 2020 |
| Corrigendum: Cytomegalovirus-mediated T cell receptor repertoire perturbation is present in early life M Attaf, J Roider, A Malik, CR Rafael, G Dolton, AJ Prendergast, A Leslie, ... Frontiers in Immunology 11, 633633, 2020 | 1 | 2020 |
| Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope G Dolton, C Rius, M Samiul Hasan, A Wall, B Szomolay, E Behiry, A Fuller, ... Cell 185 (16), P2936-2951.E19, 2022 | | 2022 |
| Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 (vol 12, pg 125, 2020) MD Crowther, G Dolton, M Legut, ME Caillaud, A Lloyd, M Attaf, ... NATURE IMMUNOLOGY 21 (6), 695-695, 2020 | | 2020 |
